A multidisciplinary approach to the treatment of synonasal polyposis: a clinical case

Sinonasal polyposis is a painless polypoid growth of the nasal mucosa and paranasal sinuses. According to various sources, the prevalence of polyps to one degree or other ranges from 1 to 5 % in the population, according to epidemiological studies conducted in Russia, polypous rhinosinusitis was detected in 1–1.3 % of those examined, thus in our country from this disease over 1.8 million people can suffer.

The disease develops more often in adults and children over 15 years of age, in percentage terms more often in men. Reaching large sizes with an uncontrolled course, nasal polyps can squeeze, destroy and deform the nearest bone structures, increasing the risk of the formation of infectious processes in nearby organs, causing purulent complications (purulent meningoencephalitis, meningitis, brain abscesses). Despite the fact that at the present stage of development of medical care, the diagnosis and control of the course of nasal polyposis is not difficult, it is not always possible to achieve satisfactory clinical results of treatment. The reasons for this may be both low patient compliance and the peculiarities of the course of synonasal polyposis, for example, the rapid and aggressive growth of polyps. Considering the urgency of the problem, epidemiology and possible difficulties in the treatment of nasal polyps, we present a description of a clinical case of a middleaged patient with synonasal polyposis as part of the aspirin triad.

1. Karpishchenko S. A., Vereshchagina O. E., Osipenko E. V. Benign neoplasms of the paranasal sinuses. Prakticheskaya medicina. 2015;2(87):104–108. (In Russ.).

2. Eschenbacher WH, Borish L. Nasal polyposis and future risk of sinonasal malignancy. J Allergy Clin Immunol. 2019;144(4):933–934. https://doi.org/10.1016/j.jaci.2019.08.015

3. Ta NH. Will we ever cure nasal polyps? Ann R Coll Surg Engl. 2019;101(1):35–39. https://doi.org/10.1308/rcsann.2018.0149

4. Kozlov VS, Savlevich EL. Chronic rhinosinusitis with nasal polyps. The recent trend in the studies of the pathogenesis, diagnosis and treatment of this disease. Vestnik otorinolaringologii. 2015;80(4):95–99. (In Russ.) https://doi.org/10.17116/otorino201580495–99

5. Van Zele T, Gevaert P, Watelet JB, et al. Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis. J Allergy Clin Immunol. 2004;114(4):981–983. https://doi.org/10.1016/j.jaci.2004.07.013

6. Ryazancev S. V., Artyushkina V.K., Nacharov P. V., Laptieva M. A. Modern aspects of systemic corticosteroid therapy in patients with chronic polypous rhinosinusitis. Rossijskaya otorinolaringologiya. 2013; 2:114–121. (In Russ.).

7. Stevens WW, Schleimer RP, Kern RC. Chronic Rhinosinusitis with Nasal Polyps. J Allergy Clin Immunol Pract. 2016;4(4):565–572. https://doi.org/10.1016/j.jaip.2016.04.012

8. Nagase H, Ueki S, Fujieda S. The roles of IL 5 and anti-IL 5 treatment in eosinophilic diseases: Asthma, eosinophilic granulomatosis with polyangiitis, and eosinophilic chronic rhinosinusitis. Allergol Int. 2020;69(2):178–186. https://doi.org/10.1016/j.alit.2020.02.002